Ajooni Biotech Limited has informed the Exchange regarding 'Confirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Quarter Ended on 31st March, 2026'.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajooni Biotech Limited has submitted a routine regulatory compliance certificate for Q4 (January-March 2026). The company's Registrar and Transfer Agent, Cameo Corporate Services Limited, confirmed that securities received for dematerialization during the quarter were properly processed and confirmed to depositories. The certificate also confirms that physical security certificates were mutilated and cancelled, and depositories were substituted as registered owners in the register of members within the stipulated time limit. This filing is a standard quarterly requirement under SEBI regulations and does not contain any material business information.
This is a routine compliance filing with no direct impact on the company's financials or stock price. It simply confirms proper handling of share dematerialization processes as required by SEBI regulations.